• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Call Text Chat Email Refer a Patient Join a Study

Search

Hide Search
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Shopping Cart
Show SearchSearch
  • About
    • Our Work
    • Our Team
    • About OTIS
    • In Your Area
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Webinars
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Annual Meeting
    • Exhibiting Schedule
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • Donate
  • Contact
  • Show SearchSearch

Verapamil

May 1, 2025

Selected References:

  • Andersen HJ. 1983. Excretion of verapamil in human milk. Eur J Clin Pharmacol, 25:279-80.
  • Anderson P, et al. 1987. Verapamil and norverapamil in plasma and breast milk during breast feeding. Eur J Clin Pharmacol, 31:625-627.
  • Belfort MA, et al. 1990. Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension. Obstet Gynecol, 75:970-974.
  • Benoff S, et al. 1994. The effect of calcium ion channel blockers on sperm fertilization potential. Fertil Steril, 62:606-617.
  • Byerly WG, et al. 1991. Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Ann Emerg Med, 20(5):552-554.
  • Czeizel AE, Rockenbauer M. 1997. Population-based case-control study of teratogenic potential of corticosteroids. Teratology, 56:335-340.
  • Czeizel AE, Toth M. 1998. Birth weight, gestational age and medications during pregnancy. Int J Gynaecol Obstet, 60:245-249.
  • Fearrington EL, et al. 1983. Hyperprolactinemia-galactorrhea induced by verapamil. Am J Cardiol, 51:1466-1467.
  • Gluskin LE, et al. 1981. Verapamil-induced hyperprolactinemia and galactorrhea. Ann Intern Med, 95:66-67.
  • Inoue H. 1984. Excretion of verapamil in human milk. Br Med J, 288:645-646.
  • Joglar JA, et al. 2023. HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm. 20: e175–264.
  • Katsoff D, Check JH. 1997. A challenge to the concept that the use of calcium channel blockers causes reversible male infertility. Hum Reprod, 12(7):1480-482.
  • King BD, et al. 1983. Impotence during therapy with verapamil. Arch Intern Med, 143:1248-1249.
  • Magee LA, et al. 1996. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol, 174(3):823-828.
  • Miller MR, et al. 1986. Verapamil and breast-feeding. Eur J Clin Pharmacol, 30:125-126.
  • Murad SHN, et al. 1985. Effects of verapamil on uterine blood flow and maternal cardiovascular function in the awake pregnant ewe. Anesth Analg, 64:7-10.
  • Spelger G, et al. 1980. Kardiale Parameter beim Neugeborenen nach Tokolyse [Cardiac parameters of the newborn after tocolysis (author’s transl)]. Klin Padiatr, 192(4):319-324. German.
  • Tamirisa KP, 2022. Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration. J Cardiovasc Dev Dis, 9:199.
  • Tektemur A, et al. 2020. Verapamil-induced ion channel and miRNA expression changes in rat testis and/or spermatozoa may be associated with male infertility. Andrologia, 52(10):e13778.
  • Weber-Schoendorfer C, et al. 2008. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol, 2008;26:24-30.
  • 2025. Product labeling. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3283bba6-05dd-3766-e063-6394a90ada69

 

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.